🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525271-57-00
Completed Phase I

A research study looking into how a single dose of the medicine NNC0537-1482 moves through the body of participants with normal or reduced kidney function

2026-525271-57-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
10/08/2026
Enrollment target
54
Sites
Germany

Condition studied

Heart failure with preserved ejection fraction

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525271-57-00 on CTIS ↗ ← All trials in the EU